Converting non-neutralizing SARS-CoV-2 antibodies into broad-spectrum inhibitors
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1552-4469
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Converting non-neutralizing SARS-CoV-2 antibodies into broad-spectrum inhibitors ; volume:18 ; number:11 ; day:8 ; month:9 ; year:2022 ; pages:1270-1276 ; date:11.2022
Nature chemical biology ; 18, Heft 11 (8.9.2022), 1270-1276, 11.2022
- Urheber
-
Weidenbacher, Payton A.-B
Waltari, Eric
de los Rios Kobara, Izumi
Bell, Benjamin N.
Morris, Mary Kate
Cheng, Ya-Chen
Hanson, Carl
Pak, John E.
Kim, Peter S.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41589-022-01140-1
- URN
-
urn:nbn:de:101:1-2023011021172970076901
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:38 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Weidenbacher, Payton A.-B
- Waltari, Eric
- de los Rios Kobara, Izumi
- Bell, Benjamin N.
- Morris, Mary Kate
- Cheng, Ya-Chen
- Hanson, Carl
- Pak, John E.
- Kim, Peter S.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Development of broad‐spectrum human monoclonal antibodies for rabies post‐exposure prophylaxis
Broad-spectrum inflammasome inhibition by thiomuscimol
A potent broad-spectrum neutralizing antibody targeting a conserved region of the prefusion RSV F protein
Advanced molecular tweezers as broad-spectrum antivirals
Synthetic optimization of cystobactamids as broad-spectrum antibiotics
Novel quinoline derivatives with broad‐spectrum antiprotozoal activities
A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates
Targeting papain-like protease for broad-spectrum coronavirus inhibition
Broad-spectrum CRISPR-Cas13a enables efficient phage genome editing
Computer‐Aided Discovery of Potent Broad‐Spectrum Vaccine Adjuvants
Hydrazinated geraniol derivatives as potential broad‐spectrum antiprotozoal agents
Silver nanoparticles are broad-spectrum bactericidal and virucidal compounds
Development of broad‐spectrum human monoclonal antibodies for rabies post‐exposure prophylaxis
Broad-spectrum inflammasome inhibition by thiomuscimol
A potent broad-spectrum neutralizing antibody targeting a conserved region of the prefusion RSV F protein
Advanced molecular tweezers as broad-spectrum antivirals
Synthetic optimization of cystobactamids as broad-spectrum antibiotics
Novel quinoline derivatives with broad‐spectrum antiprotozoal activities
A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates
Targeting papain-like protease for broad-spectrum coronavirus inhibition
Broad-spectrum CRISPR-Cas13a enables efficient phage genome editing
Computer‐Aided Discovery of Potent Broad‐Spectrum Vaccine Adjuvants
Hydrazinated geraniol derivatives as potential broad‐spectrum antiprotozoal agents
Silver nanoparticles are broad-spectrum bactericidal and virucidal compounds
Development of broad‐spectrum human monoclonal antibodies for rabies post‐exposure prophylaxis
Broad-spectrum inflammasome inhibition by thiomuscimol
A potent broad-spectrum neutralizing antibody targeting a conserved region of the prefusion RSV F protein
Advanced molecular tweezers as broad-spectrum antivirals
Synthetic optimization of cystobactamids as broad-spectrum antibiotics
Novel quinoline derivatives with broad‐spectrum antiprotozoal activities
A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates
Targeting papain-like protease for broad-spectrum coronavirus inhibition
Broad-spectrum CRISPR-Cas13a enables efficient phage genome editing
Computer‐Aided Discovery of Potent Broad‐Spectrum Vaccine Adjuvants
Hydrazinated geraniol derivatives as potential broad‐spectrum antiprotozoal agents